Sichuan Hebang Biotechnology Hits Day Low of CNY 2.80 Amid Price Pressure

Sichuan Hebang Biotechnology Co., Ltd. experienced a notable decline today, with the stock dropping by 4.42% on March 3, 2026. The stock reached an intraday low of CNY 2.80, reflecting a challenging trading session. Despite this downturn, the company has shown a strong performance over the past month, with a 15.64% increase compared to the China Shanghai Composite's decline of 1.37%. Over the past year, Sichuan Hebang has delivered a substantial return of 50.27%, significantly outperforming the composite index, which rose by 22.49%. However, the stock's three-year performance indicates a decline of 10.51%, contrasting sharply with the composite's growth of 24.3%. Financial metrics reveal that the company has faced difficulties, with net sales declining by 13.24% in the latest half-year results. Additionally, the company has reported negative results for ten consecutive quarters, raising concerns about its long-term growth prospects. With a market capitalization of CNY 21,018 million, Sichuan Hebang operates within the Chemicals & Petrochemicals industry, but its current financial indicators suggest a need for strategic reassessment.